Wolf-Karsten Hofmann

Megakaryocytic growth factors: is there a new approach for management of thrombocytopenia in patients with malignancies?

O. Ottmann, D. Hoelzer, O. Ottmann, 1999, Leukemia.

Comparison of toxicity and outcome in patients with acute myeloid leukemia treated with high-dose cytosine arabinoside consolidation after induction with a regimen containing idarubicin or daunorubicin

W. Hofmann, O. Ottmann, B. Wassmann, 1998, Annals of Hematology.

Allelotype analysis of the myelodysplastic syndrome

D. Xie, H. Koeffler, D. Hoelzer, 2000, Leukemia.

Treatment of patients with low-risk myelodysplastic syndromes using a combination of all-trans retinoic acid, interferon alpha, and granulocyte colony-stimulating factor

A. Ganser, W. Hofmann, K. Höffken, 1999, Annals of Hematology.

Inhibitory effect of imatinib on normal progenitor cells in vitro

T. Brümmendorf, S. Balabanov, A. Boehmler, 2003 .

Transforming growth factor-beta1 interferes with thrombopoietin-induced signal transduction in megakaryoblastic and erythroleukemic cells.

W. Hofmann, S. Koschmieder, O. Ottmann, 2001, Experimental hematology.